PNU-282987
- 2 independent labs in 1 country
- Funders: Key Research and Development Program of Ningxia and 3 more
- Humans1
- Animals1
Outcomes
5Cellular senescence
downin cells1
1 study
Cellular senescence
downin cells1
PNU-282987 inhibits cellular senescence in cells.
“RNA-seq confirmed that PNU treatment normalised gene expression profiles associated with endoplasmic reticulum stress and cellular senescence.”
Cellshyperglycaemic conditions
Diabetologia15 Dec 2025
Oxidative stress and ROS signalling
downin cells1
1 study
Oxidative stress and ROS signalling
downin cells1
PNU-282987 decreases oxidative stress and ROS signalling in cells.
“Pharmacological activation of α7nAChR with PNU or GTS-21 restored α7nAChR-VDAC1 coupling, attenuated p66Shc-mediated oxidative stress and reversed mitochondrial Ca2+ overload.”
Cellshyperglycaemic conditions
Diabetologia15 Dec 2025
NRF2–KEAP1 antioxidant response
upin rats1
1 study
NRF2–KEAP1 antioxidant response
upin rats1
PNU-282987 activates NRF2–KEAP1 antioxidant response in rats.
“effective activation of the α7nAChR mediated Nrf2/HO-1 signaling pathway and antioxidant activity by specific agonist, PNU282987”
Animals
Archives of gerontology and geriatrics28 Oct 2025
Senescence-associated beta-galactosidase
downin rats1
1 study
Senescence-associated beta-galactosidase
downin rats1
PNU-282987 decreases senescence-associated beta-galactosidase in rats.
“decreased senescence-associated β-galactosidase activity, phosphorylation of H2A.XSer139, expression of p21 and p16INK4a and inflammation”
Animals
Archives of gerontology and geriatrics28 Oct 2025
Vascular aging
downin rats1
1 study
Vascular aging
downin rats1
PNU-282987 protects against vascular aging in rats.
“Activation of α7nAChR alleviated vascular aging in aged rats, as evidenced by improving endothelium-dependent vasodilatation and endothelial continuity”
Animals
Archives of gerontology and geriatrics28 Oct 2025